Gynecologic Oncology Research
Clinical trials are people-based studies -- as opposed to animal or lab studies -- of new drugs or procedures. Doctors use clinical trials to learn whether a new treatment is safe and effective in patients. Such studies are vital to the development of new treatments for diseases such as cancer.
The Division of Gynecologic Oncology is a member and active participant in the Gynecologic Oncology Group (GOG), a National Cancer Institute (NCI)-sponsored clinical-trials organization that offers the latest in clinical-trials organization that offers the latest in clinical research trials for gynecologic oncology patients. GOG is the only group which focuses its research on women with cancer of the ovary, uterus, and cervix. The Division is also a participant of industry-sponsored studies.
Rajul Kothari, MD
-GOG 0249: A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patient with High Risk, Early Stage Endometrial Carcinoma
-GOG 0263: Randomized Phase III Clinical of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIa Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy